Skip to main content
Advertisement
Live broadcast

Smell the vast: the patient's fat cells will help repair a damaged nose

New technology will simplify the treatment of injuries in children and adults
0
Photo: IZVESTIA/Sergey Lantyukhov
Озвучить текст
Select important
On
Off

Russian doctors have completed preclinical studies of a cellular product to repair damaged nasal tissues. The technology involves the use of the patient's own cells and allows to stimulate the regeneration of the mucous membrane, cartilage and bone tissue, practically restoring the organ. According to doctors, severe nasal injuries remain a serious problem that cannot always be solved even after several operations. The experiments have shown that after the application of the cellular product, tissues are formed, the characteristics of which are close to natural. The technology is planned to be used, among other things, to repair serious injuries in children. The first operations may begin as early as this year.

Cellular product for nose repair

Scientists at Sechenov University have completed preclinical studies of the individual biomedical cellular product Sechenovrino to repair damaged structures of the nasal cavity. Experiments have shown that cell therapy stimulates the regeneration of the mucous membrane, cartilage and bone tissue and prevents excessive scarring. Specialists plan to perform the first operations on patients no later than the beginning of 2027.

Existing surgical methods generally allow for mechanical closure or replacement of the damaged area, but they do not always restore the complex structure of the mucous membrane and other tissues. Because of this, scarring may persist and relapses may occur.

— For such patients, the problem is not limited to the presence of a hole or a lack of tissue volume. It is necessary to restore the normal architecture of the nasal cavity, the mucous membrane, the vascular network, the cartilaginous or bony framework — all that depends on the normal passage and treatment of air. Therefore, the result of the preclinical study is especially important for us: after applying the development, the tissues approached normal in terms of basic morphological parameters," said Alexander Maltsev, assistant professor at the Department of Ear, Throat and Nose Diseases at the Institute of Clinical Medicine at Sechenov University.

The technology is based on spheroids from mesenchymal stromal (a type of stem) cells, which are obtained from a small fragment of the patient's own adipose tissue. The cells are combined into three-dimensional structures and injected directly into the lesion area. They secrete a complex of biologically active substances that regulate inflammation, stimulate vascular growth and trigger their own tissue regeneration mechanisms.

One of the main indications for the new technology is persistent perforations of the nasal septum and empty nose syndrome. These are serious conditions that can occur after injuries and surgical procedures. During perforation, a through defect forms between the nasal passages, which disrupts the movement of air. Patients may be worried for years about dryness, crusting, bleeding, wheezing, stuffiness, and decreased sense of smell.

Even more difficult is the empty nose syndrome, which can develop after operations that disrupt the normal anatomy of the nasal cavity. Despite the physically free nasal passages, a person may experience a painful feeling of lack of air, constant dryness and burning sensation. Due to changes in aerodynamics, the nose stops warming, humidifying and purifying the air normally. Such symptoms significantly reduce the quality of life and are extremely difficult to treat.

Practical application

The effectiveness of the technology was evaluated on two chronic models: persistent perforation of the nasal septum and damage to the lower nasal concha, simulating empty nose syndrome. Two months after the introduction of the cellular product, the researchers observed marked tissue repair: in most cases, the perforation had completely closed, and the formed tissues were approaching normal in terms of basic morphological characteristics. In the model of empty nose syndrome, tissue parameters after therapy also practically did not differ from natural ones. Significantly more pronounced inflammatory processes and regeneration disorders persisted in the control groups. The study did not reveal significant toxic reactions or signs of rejection of the cellular product.

— We have reached the stage when the results of preclinical studies allow us to move towards the use of technology in patients. We expect to start the first operations before the end of this year or early next year. Patients with such conditions are already contacting us, and a waiting list for treatment has been formed. For many of them, the existing possibilities of surgery are limited, so our task is not just to close the defect, but to restore our own full—fledged tissue," said Mikhail Svistushkin, associate professor at the Department of Ear, Throat and Nose Diseases at the Institute of Clinical Medicine.

According to practicing ENT specialists, restoring the complex structure of the nose after injuries remains a difficult task today, and doctors have limited options for solving it.

— Such damages are difficult to correct. Even repeated surgical procedures do not always bring results. The possibility of using stem cells for regeneration has been considered for quite some time," ENT surgeon Natalia Lukan told Izvestia.

According to Andrey Prodeus, chief pediatric allergist and immunologist at the Ministry of Health of the Moscow Region, the technology can potentially be used in such sensitive cases as severe injuries in children, for example, as a result of animal attacks or disasters. However, in his opinion, there is still insufficient data from long-term observations that would allow us to assess how the restored tissues will behave many years later.

According to Maria Vedunova, director of the Institute of Biology and Biomedicine at UNN, adipose tissue used in reconstructive surgery contains cells that are genetically compatible with the patient's body. They have a pronounced secretory activity, due to which they can participate in tissue regeneration. Technologies are currently being developed that make it possible to change the properties of such cells specifically for specific tasks. However, according to the expert, such approaches require caution due to the potential risk of cancer complications. At the same time, simple stimulation of the body's own regenerative processes may be less effective, but potentially safer.

Переведено сервисом «Яндекс Переводчик»

Live broadcast